ロード中...
Reversing multidrug resistance by tyrosine kinase inhibitors
Recently, a large number of tyrosine kinase inhibitors (TKIs) have been developed as anticancer agents. These TKIs can specifically and selectively inhibit tumor cell growth and metastasis by targeting various tyrosine kinases and thereby interfering with cellular signaling pathways. The therapeutic...
保存先:
| 主要な著者: | , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Sun Yat-sen University Cancer Center
2012
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3777484/ https://ncbi.nlm.nih.gov/pubmed/22237041 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5732/cjc.011.10315 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|